Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours By Ogkologos - March 2, 2026 3 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PYNNACLE study Source RELATED ARTICLESMORE FROM AUTHOR Rare Disease Day 2026: Advancing equity for people living with rare cancers in Europe EMA Recommends Extension of Therapeutic Indications for Ponatinib Screening Programme by Primary Colonoscopy or Two Rounds of Two-Stool FIT Detects More Lower-Stage CRCs than Usual Care MOST POPULAR Ethnic Diversity and Disparities in Access to Genetic Testing Impact Prostate... November 28, 2022 Expecting Mom Finds Pregnant Stray Cat And Gives Her A Home July 30, 2021 Metastatic Breast Cancer: New ESMO Guideline With Evidence-Based Recommendations [ESMO Press... October 19, 2021 Trial Results Support Adding Daratumumab to Initial Treatment for Multiple Myeloma January 19, 2024 Load more HOT NEWS Sugar Compound Found in Breast Milk May Help Ease Chemotherapy Side... Man Who Lost Wife to Breast Cancer Wants to Donate Her... A Third Dose of BNT162b2 is Safe and Improves Humoural Immunity... What Survivors Should Know When Transitioning From Cancer Care to Primary...
